Abstract: Cerebrovascular diseases, which include ischemic and hemorrhagic strokes, remain serious conditions with high mortality and disability worldwide (He et al., 2018). Ischemic stroke accounts for around 80% of all strokes (He et al., 2018). Hemorrhagic stroke consisting of intracerebral hemorrhage and subarachnoid hemorrhage (SAH) occurs less frequently but may cause poorer outcomes than ischemic stroke (Ji et al., 2017; Luo et al., 2018). It is also well known that aneurysmal SAH may have delayed cerebral ischemia (DCI): thus aneurysmal SAH has both characteristics of hemorrhagic and ischemic strokes (Kanamaru et al., 2019). In spite of enormous efforts to improve outcomes, no conclusive treatment exists thus far, once stroke is completed.